THE IMPACT OF MUSCULAR STRENGTH ON THE SIT-TO-STAND TASK IN INDIVIDUALS WITH PARKINSON’S DISEASE
Article Sidebar
Main Article Content
Аннотация:
Parkinson’s disease (PD) is a neurological condition characterized by the degeneration of dopaminergic cells in the substantia nigra [1]. Individuals with PD experience a range of motor and nonmotor symptoms throughout the progression of the disease. While bradykinesia, muscle rigidity, and tremors are commonly recognized motor symptoms, patients often report difficulties in activities such as rising from a chair or performing the sit-to-stand (STS) task [2]. The STS task holds significant importance in overall mobility, determining functional independence, and influencing the quality of life [2, 3]. It is estimated that approximately 44% of PD patients encounter some level of difficulty in performing this task [2].
Article Details
Как цитировать:
Библиографические ссылки:
J. Jankovic, “Parkinson's disease: clinical features and diagnosis,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 79, no. 4, pp. 368–376, 2008
M. Bishop, D. Brunt, N. Pathare, M. Ko, and J. Marjama-Lyons, “Changes in distal muscle timing may contribute to slowness during sit to stand in Parkinsons disease,” Clinical biomechanics, vol. 20, no. 1, pp. 112–117, 2005.
V. L. Domingues, J. E. Pompeu, T. B. de Freitas, J. Polese, and C. Torriani-Pasin, “Physical activity level is associated with gait performance and five times sit-to-stand in Parkinson's disease individuals,” Acta Neurologica Belgica, vol. 122, no. 1, pp. 191–196, 2022.
E. Nikfekr, K. Kerr, S. Attfield, and E. Playford, “Trunk movement in Parkinson's disease during rising from seated position,” Movement Disorders, vol. 17, no. 2, pp. 274–282, 2002.
L. M. Inkster, J. J. Eng, D. L. MacIntyre, and A. J. Stoessl, “Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair,” Movement Disorders, vol. 18, no. 2, pp. 157–162, 2003.
M. K. Mak, F. Yang, and Y. C. Pai, “Limb collapse, rather than instability, causes failure in sit-to-stand performance among patients with Parkinson disease,” Physical Therapy, vol. 91, no. 3, pp. 381–391, 2011.
J. H. Friedman and A. M. Abrantes, “Self perceived weakness in Parkinson's disease,” Parkinsonism & Related Disorders, vol. 18, no. 7, pp. 887–889, 2012.
M. Alonso-Juarez, R. Fekete, and J. F. Baizabal-Carvallo, “Objective and self-perceived lower limb weakness in Parkinson's disease,” Therapeutic advances in neurological disorders, vol. 15, Article ID 175628642211369, 2022.
W. Koller and S. Kase, “Muscle strength testing in Parkinson's disease,” European Neurology, vol. 25, no. 2, pp. 130–133, 1986.
H. Nogaki, S. Kakinuma, and M. Morimatsu, “Muscle weakness in Parkinson's disease: a follow-up study,” Parkinsonism & Related Disorders, vol. 8, no. 1, pp. 57–62, 2001.
S. S. Paul, C. G. Canning, C. Sherrington, and V. S. Fung, “Reduced muscle strength is the major determinant of reduced leg muscle power in Parkinson's disease,” Parkinsonism & Related Disorders, vol. 18, no. 8, pp. 974–977, 2012.
J. Stevens-Lapsley, B. M. Kluger, and M. Schenkman, “Quadriceps muscle weakness, activation deficits, and fatigue with Parkinson disease,” Neurorehabilitation and Neural Repair, vol. 26, no. 5, pp. 533–541, 2012.
V. K. Ramsey, T. A. Miszko, and M. Horvat, “Muscle activation and force production in Parkinson's patients during sit to stand transfers,” Clinical biomechanics, vol. 19, no. 4, pp. 377–384, 2004.
A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees, “Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 55, no. 3, pp. 181–184, 1992.
C. G. Goetz, W. Poewe, O. Rascol et al., “Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations the movement disorder society task force on rating scales for Parkinson's disease,” Movement Disorders, vol. 19, no. 9, pp. 1020–1028, 2004.